Dosing Protocol
Typical Dose 150 mg
Range 50 - 250 mg
Maintenance 150 mg weekly
Pharmacokinetics
Half-Life 8.0 days
Onset 1.0 days
Peak 3.0 days
Duration 14.0 days
Bioavailability 100%
Primary Route Intramuscular
Administration
Routes Intramuscular, Subcutaneous
Injection Sites Glute, Quad, Deltoid, Ventrogluteal
Needle Gauge 22-25G
Syringe Type Standard
Timing Morning, Any Time
Vial Sizes 100, 200, 250, 1000 mg
Stability 90 days
Special Instructions
Draw with 18G needle, inject with 22-25G. Warm vial before injection. Rotate injection sites.